Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls

NCT00466310 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00466310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00466310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2007
Completion date
January 31, 2011
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia